Constitutive activity of NF-κB has been reported in a number of cancers [14], [15], [16], [17], [18], [19], [20] and is known to inhibit apoptosis and promote tumorigenesis through regulation of proliferation, angiogenesis, invasion, and metastasis [21], [22], [23], [24]. The gene discussed is NFKB1; the disease is cancer.